Trial Profile
Pharmacokinetic interaction trial between ticagrelor and tolbutamide in volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Dec 2015
Price :
$35
*
At a glance
- Drugs Ticagrelor (Primary) ; Tolbutamide (Primary)
- Indications Acute coronary syndromes; Diabetes mellitus; Thromboembolism
- Focus Pharmacokinetics
- Sponsors AstraZeneca
- 13 Aug 2013 New trial record